Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Molecular Medicine Reports|January 22, 2015
Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitorShanshan Shi, Chenxing Yuan, Kaizan Zhuang, et al.
Translational Lung Cancer Research|February 11, 2021
The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatmentShenglin Ma, Meiqi Shi, Xueqin Chen, et al.
Nature Communications|August 29, 2022
Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequencyJinhui Zhang, Haimin Yao, Jiaying Mo, et al.
Open Medicine (Warsaw, Poland)|March 9, 2019
Regional Hyperthermia Combined with Chemotherapy in Advanced Gastric CancerHongming Fang, Yaping Zhang, Zhibing Wu, et al.
Annals of Translational Medicine|January 20, 2023
Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolismJuan Shen, Jie Huang, Yu Huang, et al.
Oncotarget|October 15, 2014
Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signalingJun Zhang, Ji Cao, Shenglin Ma, et al.
Frontiers in Pharmacology|May 24, 2021
Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World StudyXin Li, Jie Huang, Yao Qiu, et al.
Future Oncology (London, England)|May 1, 2019
Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based studyQingying Yan, Kai Zhang, Kaibo Guo, et al.
Cancer Letters|October 14, 2021
SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancerJingjing Zhang, Qiong Wu, Lucheng Zhu, et al.
Molecular Cancer Therapeutics|February 4, 2016
Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung CancerJianguo Feng, Shirong Zhang, Kan Wu, et al.
Pageof 22